about
Cortical Structure Alterations and Social Behavior Impairment in p50-Deficient MiceNeuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signalingThe antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologicallyThe MMP-1/PAR-1 Axis Enhances Proliferation and Neuronal Differentiation of Adult Hippocampal Neural Progenitor CellsDopamine receptor agonists for protection and repair in Parkinson's disease.Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures.Proneurogenic Effects of Trazodone in Murine and Human Neural Progenitor Cells.Novel insights into the role of NF-κB p50 in astrocyte-mediated fate specification of adult neural progenitor cells.Every Cloud Has a Silver Lining: Proneurogenic Effects of Aβ Oligomers and HMGB-1 via Activation of the RAGE-NF-κB Axis.Cell autonomous and noncell-autonomous role of NF-κB p50 in astrocyte-mediated fate specification of adult neural progenitor cells.Nuclear factor κB-dependent neurite remodeling is mediated by Notch pathway.Ecdysone-based system for controlled inducible expression of metabotropic glutamate receptor subtypes 2, 5, and 8.Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene.Tumor necrosis factor alpha mediates a T cell receptor-independent induction of the gene regulatory factor NF-kappa B in T lymphocytes.Upregulation of mGlu2 receptors via NF-κB p65 acetylation is involved in the Proneurogenic and antidepressant effects of acetyl-L-carnitine.NF-κB mediated regulation of adult hippocampal neurogenesis: relevance to mood disorders and antidepressant activity.Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. I. Frontal cortex.Not only a bad guy: potential proneurogenic role of the RAGE/NF-κB axis in Alzheimer's disease brain.Chronic pain and adult hippocampal neurogenesis: translational implications from preclinical studies.Contribution of NF-kappaB and p53 in the glutamate-induced apoptosis.Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain.Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain.The noradrenergic component in tapentadol action counteracts μ-opioid receptor-mediated adverse effects on adult neurogenesis.α2δ ligands act as positive modulators of adult hippocampal neurogenesis and prevent depression-like behavior induced by chronic restraint stress.Members of the NF-kappaB family expressed in zones of active neurogenesis in the postnatal and adult mouse brain.Tricyclic thienopyridine-pyrimidones/thienopyrimidine-pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain.Impaired adult neurogenesis associated with short-term memory defects in NF-kappaB p50-deficient mice.l-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug.High-mobility group box-1 protein and β-amyloid oligomers promote neuronal differentiation of adult hippocampal neural progenitors via receptor for advanced glycation end products/nuclear factor-κB axis: relevance for Alzheimer's disease.Early growth response 2 (Egr-2) expression is triggered by NF-κB activation.Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.Adult dorsal root ganglia sensory neurons express the early neuronal fate marker doublecortin.Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.Gene expression, proteome and calcium signaling alterations in immortalized hippocampal astrocytes from an Alzheimer's disease mouse modelTapentadol: an effective option for the treatment of back pain.Evidence for the involvement of distinct voltage-sensitive calcium channels in the release of 3H-dopamine from primary cultures of mesencephalic neuronsInterleukin-10 modulates neuronal threshold of vulnerability to ischaemic damageCorrection: Gene expression, proteome and calcium signaling alterations in immortalized hippocampal astrocytes from an Alzheimer's disease mouse modelPharmacological rationale for tapentadol therapy: a review of new evidence
P50
Q28394415-5DFD396E-C623-4F50-B6BB-843860F22E4BQ34203214-D72B201B-B896-4386-B083-28EAEE5F84D2Q34389636-840B63D9-F5F8-45DF-B059-3B9F7A601441Q35826855-C67D56CA-5740-4335-8679-D9636A7ADCD0Q36405269-1EA3A608-C855-4BC4-9A51-E5E49FA34CE7Q37239958-E25BBB17-724E-410D-B1D9-DD1C971D0300Q38356337-AA585178-45C1-456F-97BC-2ACA18D419FAQ38715690-0A74F2EC-9B11-4E3D-B88E-A3B62C165784Q38806089-3D353CF7-1301-4F45-81B3-80565611E04BQ38917568-FF78C91A-1F0F-4B83-B41E-BE1C91E5F14AQ39272917-BFDF644A-51CC-48B7-BAB9-C7F44D2640ABQ39718852-57354323-F638-410F-B660-6F84B5FA91B3Q40360459-256C1D14-4A9B-45F3-8CD0-D309155E8CE3Q41271788-2FE00D4B-0B3B-4957-AC42-6CB5CA6ED929Q41521637-859AB375-9775-47C9-B017-0205F031DC2CQ41839624-2CA6044F-E45C-413B-BB9F-6036254079D0Q41960088-2DAF2E38-BC86-40DB-8E5A-113AD64D7928Q42202486-0F6AEA15-1160-4273-9DB8-AB293490A4A1Q42327757-FF0F94DA-CDD9-4172-B373-9EAF6D323E85Q42364438-C144FB03-F22A-4EC9-A66A-09E7DE701376Q42488237-3485487F-E548-458B-8813-51BA13AC81C8Q42715212-C6386DA6-3279-4394-A124-D1C338033DDEQ42722220-F8148081-FB72-4CE9-A083-B7DEF63F6743Q44343339-9372B322-9F8A-482B-9FB3-4E6681CA746EQ44571543-31BC1CD6-0D36-4636-AA03-CFB6440E3257Q45200275-683C687B-F0C8-49EA-8BC9-65679621ABBCQ46016056-4C7893C2-6B00-4CCB-B22B-545ABEAFC70EQ46653950-F5134464-941B-4DDD-AD8B-2644652926BCQ47268040-8723190D-6905-447B-AC22-0BFF7CDC0D06Q48097957-1B7F17BE-34FD-4D5D-9CBE-8BB6359B0484Q48393413-4B7AE973-C2EB-4E75-AC47-C1A765AA8BD8Q48859321-04867B52-9262-4959-A4E8-8F57E24AE791Q48919663-ECA926D1-0E69-47C6-AD20-AEF2BAAA8DA9Q48933018-629C645A-DB04-4DD8-8BDD-169F99C3B549Q60912540-F08BFD45-16C5-40FF-AE7C-3212B2D301B2Q64917121-F8ECA940-B3B5-44DD-88D2-26B88EB565E7Q69361012-ED89D405-5C36-4340-81ED-4193E9370DB7Q74187418-226F9718-B1EB-4C2E-A45D-A85C85F1AF29Q91999304-C9B43F32-FDA6-4B9A-965C-8A5F53FFF286Q92697327-CBA0A298-F4B2-464E-8D1C-A78F4CE19E62
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mariagrazia Grilli
@ast
Mariagrazia Grilli
@en
Mariagrazia Grilli
@es
Mariagrazia Grilli
@nl
type
label
Mariagrazia Grilli
@ast
Mariagrazia Grilli
@en
Mariagrazia Grilli
@es
Mariagrazia Grilli
@nl
prefLabel
Mariagrazia Grilli
@ast
Mariagrazia Grilli
@en
Mariagrazia Grilli
@es
Mariagrazia Grilli
@nl
P106
P31
P4012
P496
0000-0001-9165-5827